What is it about?

The role of drug metabolism enzymes as biomarkers of disease susceptibility in ALS.

Featured Image

Why is it important?

The first report of a defect in drug metabolism in subjects with ALS.

Read the Original

This page is a summary of: XENOBIOTIC METABOLISM IN MOTORNEURON DISEASE, The Lancet, September 1988, Elsevier, DOI: 10.1016/s0140-6736(88)90467-9.
You can read the full text:



Be the first to contribute to this page